Cardio IQ® Advanced Lipid Panel and Inflammation Panel

The 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults recommend matching the intensity of statin treatment with the absolute risk of cardiovascular events. However, the standard lipid panel alone does not provide a complete assessment of absolute risk of CVD. Adding advanced CVD markers (ion mobility, apob, lp(a), hs crp and lppla2) in addition to the lipid panel will improve assessment of the CVD risk. Includes: Cardio IQ® Cholesterol, Total Cardio IQ® HDL Cholesterol Cardio IQ® Triglycerides Cardio IQ® Non-HDL and Calculated Components Cardio IQ® Lipoprotein Fractionation, Ion Mobility Cardio IQ® Apolipoprotein B Cardio IQ® Lipoprotein (a) Cardio IQ® hs-CRP Cardio IQ® Lp-PLA2 Activity